100
NPS
Learn More about Brand Intelligence Solutions
Find out what hundreds of thousands of customers are saying about your brand, your competitors and others in the industry
Thank you for inquiring about Comparably's Brand Intelligence Solutions
A member from Comparably's team member will be reaching out shortly to set up a time to speak about our Brand Intelligence Solutions
Brand Page
Audentes Therapeutics
Marketing or Exec? Claim Your Free Account
About Audentes Therapeutics' Brand
Audentes is a biotechnology company that employs gene therapy technology to develop treatments for people with rare muscle diseases. Among its major competitors, Audentes Therapeutics is ranked in 3rd place for NPS while Spark Therapeutics is 1st, and Homology Medicines is 2nd.Their current market cap is $2.73B
Brand at a Glance
5/5
Product Quality
Audentes Therapeutics Ranking
- #2 / 4 of its competitors
Audentes Therapeutics NPS
Audentes Therapeutics's Net Promoter Score (NPS) is a 100 with 100% Promoters, 0% Passives, and 0% Detractors. Net Promoter Score tracks whether Audentes Therapeutics's customers would recommend using the product based on a scale of -100 to 100.
Audentes Therapeutics Overall NPS
| 100% | Promoters |
|---|---|
| 0% | Passives |
| 0% | Detractors |
Audentes Therapeutics NPS Trend
-100
-50
0
50
100
| Summary | Date | Score |
|---|---|---|
Jan 2021 100 | Jan 2021 | 100 |
How Other Brands Compare
Audentes Therapeutics is ranked second for NPS among its competitors. Spark Therapeutics and 23andMe come in first and third, with Voyager Therapeutics coming in at #4. Among those competitors, it is the second most valued company behind Spark Therapeutics.
Audentes Therapeutics |  23andMe |  Spark Therapeutics |  Voyager Therapeutics | |
| Global Ranking | #- | #643 | #- | #- |
| NPS | 100 | 12 | 100 | -100 |
| Social Sentiment Calculated by analyzing social media and other online mentions | - | Neutral | - | - |
| Valuation Updated every 24 hours for public companies | $2.73B | $2.50B | $4.29B | $564.66M |
What is NPS
Net Promoter Score (NPS) is a management tool that can be used to gauge the satisfaction of a firm's customer relationships. NPS has been widely adopted as a key metric often linked to the revenue potential of a company’s product or service. The metric is based on customer responses to the question: "On a scale of 0 to 10, how likely are you to recommend the product to a friend?"
Those who respond with a score of 9 to 10 are known as Promoters, and are widely associated with behaviors that create value, including actively encouraging others to use the product or service. Those who respond with a score of 7 or 8 are categorized as Passives, and they are believed to be less likely to exhibit the value-creation traits of Promoters having a largely neutral effect on other consumers. Detractors are those who fall in the score range of 0 to 6 and represent dissatisfied customers of the product sometimes actively recommending against using the product.
Audentes Therapeutics NPS vs. Competitors
Compared to its competitors, Audentes Therapeutics's NPS is rated right above 23andMe, and is preceded by Homology Medicines.
| COMPANY | NPS Score | |
|---|---|---|
| Spark Therapeutics | 100 |
 | Homology Medicines | 100 |
| Audentes Therapeutics | 100 |
| 23andMe | 12 |
| Voyager Therapeutics | -100 |
Audentes Therapeutics Product Quality
5/5
Audentes Therapeutics has an overall Product Quality score of 5 out of 5 stars rated by its users and customers.
Sign Up to unlock Audentes Therapeutics' overall Product Quality score rated by its users and customers.
Audentes Therapeutics Product Information
Audentes Therapeutics’s product quality score is a 5 out of 5 as rated by its users and customers.
- Website
- http://audentestx.com
- Company Size
- 51-200 Employees
Industry
Tech
Biotech and Pharmaceuticals
Healthcare
Audentes Therapeutics Product Quality vs. Competitors
Compared to its competitors, Audentes Therapeutics's Product Quality score is rated right above Voyager Therapeutics.
| COMPANY | Product Quality Score | |
|---|---|---|
| Audentes Therapeutics | 5/5 |
| Voyager Therapeutics | 5/5 |
| Homology Medicines | 4/5 |
| Spark Therapeutics | 3.7/5 |
| 23andMe | 3.7/5 |
Unlock Audentes Therapeutics Product Quality vs. Competitors Data
VS
Sign Up for Brand Profile PRO to get the full Audentes Therapeutics Product Quality vs. Competitors data and gain insights into your customers today.
Consumer vs. Employees
Audentes Therapeutics scored a 100 for Net Promoter Score and a -50 for Employee Net Promoter Score. NPS gauges how likely a customer of Audentes Therapeutics would recommend the brand to a friend. ENPS measures how likely Audentes Therapeutics employees would recommend working at Audentes Therapeutics to a friend.
Net Promoter Score
100
NPS Score
| 100% | Promoters |
|---|---|
| 0% | Passive |
| 0% | Detractors |
Employee Net Promoter Score
-50
eNPS Score
| 0% | Promoters |
|---|---|
| 50% | Passive |
| 50% | Detractors |
